A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- NA
Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab
- Status
- COMPLETED
- Phase
- PHASE2
Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients
- Status
- COMPLETED
- Phase
- PHASE3
Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
- Status
- TERMINATED
- Phase
- PHASE2
ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck
- Status
- COMPLETED
- Phase
- PHASE3
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2